BIAFW
IndustrialsbioAffinity Technologies Inc. Warrant
AI Insight
What's Moving BIAFW Today?
No stock-specific AI insight has been generated for BIAFW yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.05$0.81
$0.28
Fundamentals
Market Cap$445,470.25
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE-623.0%
Profit Margin-280.6%
Debt / Equity—
Trading
Volume340
Avg Volume (10D)—
Shares Outstanding—
BIAFW News
20 articles- bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy CellsYahoo Finance·Jun 22, 2026
- WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million OfferingYahoo Finance·Jun 18, 2026
- bioAffinity Technologies Announces Closing of $3.2 Million OfferingYahoo Finance·Jun 18, 2026
- bioAffinity Technologies Announces Pricing of $3.2 Million OfferingYahoo Finance·Jun 17, 2026
- bioAffinity Technologies Announces Program to Advance Veteran Lung Health: Philips, bioAffinity Technologies and 4DMedical Highlight New Approaches to Lung Health Screening for U.S. VeteransYahoo Finance·Jun 16, 2026
- Multidisciplinary Physician Panel to Share Real-World Benefits of bioAffinity Technologies’ Noninvasive CyPath Lung Cancer Test in Upcoming Society for Advanced Bronchoscopy WebinarYahoo Finance·Jun 2, 2026
- bioAffinity Technologies Announces Notification of Mexico Patent Allowance Covering Novel Lung Cancer Detection Methods Using CyPath® Lung TechnologyYahoo Finance·May 27, 2026
- BIAF Stock Slips Post Q1 Earnings Despite Strength in CyPath LungYahoo Finance·May 14, 2026
- bioAffinity Technologies Reports Record Monthly CyPath® Lung Unit Sales and Significant Year-Over-Year Growth in April 2026Yahoo Finance·May 12, 2026
- bioAffinity Technologies Reports First Quarter 2026 Results and Expanding Adoption and Clinical Usage of CyPath® LungYahoo Finance·May 8, 2026
- bioAffinity Technologies Launches New Study To Expand Use of CyPath® Lung Technology for Asthma and COPD Diagnosis and TreatmentYahoo Finance·Apr 28, 2026
- bioAffinity Stock Surges 113.8% in 3 Months: What's Driving the Rally?Yahoo Finance·Apr 16, 2026
- New Case Study: bioAffinity Technologies’ CyPath® Lung Diagnostic Supports Physician’s Assessment, Prompts Follow-Up Imaging and Defers Unnecessary BiopsyYahoo Finance·Apr 14, 2026
- bioAffinity Technologies’ CyPath® Lung to Be Featured at Cleveland Clinic Annual "Advances in Early Lung Cancer Detection" Symposium April 16Yahoo Finance·Apr 7, 2026
- bioAffinity Technologies’ CyPath® Lung Test Unit Sales Surged 146% Year-Over-Year in Q1 2026Yahoo Finance·Apr 1, 2026
- bioAffinity Technologies to Host Live Virtual Physician Roundtable on Integrating CyPath® Lung into Pulmonary PracticeYahoo Finance·Mar 25, 2026
- BC-Most Active StocksYahoo Finance·Mar 23, 2026
- New Case Study: bioAffinity Technologies’ CyPath® Lung Provides Actionable Results and Helps Patient Avoid Costly, Invasive ProceduresYahoo Finance·Mar 17, 2026
- bioAffinity Technologies Announces Validation Study with Brooke Army Medical Center to Expand Sample Collection Options for the CyPath® Lung Noninvasive Early Detection Lung Cancer TestYahoo Finance·Feb 25, 2026
- New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung CancerYahoo Finance·Feb 19, 2026
All 20 articles loaded
Price Data
Open$0.00
Previous Close$0.27
Day High$0.00
Day Low$0.00
52 Week High$0.81
52 Week Low$0.05
52-Week Range
$0.05$0.81
$0.28
Fundamentals
Market Cap$445,470.25
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE-623.0%
Profit Margin-280.6%
Debt / Equity—
Trading
Volume340
Avg Volume (10D)—
Shares Outstanding—
About bioAffinity Technologies Inc. Warrant
bioAffinity Technologies, Inc., a biotechnology company, is engaged in the development of non-invasive diagnostic tests and specific treatments for cancer. The company is headquartered in San Antonio, Texas.
IndustrialsSERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Company Details
Security TypeWarrant
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICSERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
CIK—
Composite FIGI—
Share Class FIGI—